» Articles » PMID: 28902066

Latent Class Analysis of ADHD Neurodevelopmental and Mental Health Comorbidities

Overview
Date 2017 Sep 14
PMID 28902066
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Many children diagnosed with attention-deficit/hyperactivity disorder (ADHD) experience co-occurring neurodevelopmental and psychiatric disorders, and those who do often exhibit higher levels of impairment than children with ADHD alone. This study provides a latent class analysis (LCA) approach to categorizing children with ADHD into comorbidity groups, evaluating condition expression and treatment patterns in each group.

Methods: Parent-reported data from a large probability-based national sample of children diagnosed with ADHD (2014 National Survey of the Diagnosis and Treatment of ADHD and Tourette Syndrome) were used for an LCA to identify groups of children with similar groupings of neurodevelopmental and psychiatric comorbidities among children with current ADHD (n = 2495). Differences between classes were compared using multivariate logistic regressions.

Results: LCA placed children who were indicated to have ADHD into 4 classes: (low comorbidity [LCM] [64.5%], predominantly developmental disorders [PDD] [13.7%], predominantly internalizing disorders [PID] [18.5%], and high comorbidity [HCM] [3.3%]). Children belonging to the HCM class were most likely to have a combined ADHD subtype and the highest number of impaired domains. Children belonging to the PDD class were most likely to be receiving school services, whereas children in the PID class were more likely to be taking medication than those belonging to the LCM class who were least likely to receive psychosocial treatments.

Conclusion: Latent classes based on co-occurring psychiatric conditions predicted use of varied treatments. These findings contribute to the characterization of the ADHD phenotype and may help clinicians identify how services could be best organized and coordinated in treating ADHD.

Citing Articles

Anxiety and Somatic Symptoms in Children and Adolescents Diagnosed with Attention-Deficit Hyperactivity Disorder.

Okyar E, Bozatli L, Gorker I, Okyar S Psychiatry J. 2023; 2023:5523312.

PMID: 37583678 PMC: 10425248. DOI: 10.1155/2023/5523312.


Gestational Exposure to Phthalates and Phthalate Replacements in Relation to Neurodevelopmental Delays in Early Childhood.

Park S, Zimmerman E, Huerta-Montanez G, Rosario-Pabon Z, Velez-Vega C, Cordero J Toxics. 2023; 11(1).

PMID: 36668792 PMC: 9863718. DOI: 10.3390/toxics11010065.


Children and adolescents with neurodevelopmental disorders show cognitive heterogeneity and require a person-centered approach.

Marquez-Caraveo M, Rodriguez-Valentin R, Perez-Barron V, Vazquez-Salas R, Sanchez-Ferrer J, De Castro F Sci Rep. 2021; 11(1):18463.

PMID: 34531454 PMC: 8445997. DOI: 10.1038/s41598-021-97551-6.


A Review of Predictors of Psychosocial Service Utilization in Youth with Attention-Deficit/Hyperactivity Disorder.

Green C, Langberg J Clin Child Fam Psychol Rev. 2021; 25(2):356-375.

PMID: 34498154 DOI: 10.1007/s10567-021-00368-y.


Associations between prepregnancy body mass index, gestational weight gain and weight catch-up in small-for-gestational-age children.

Huang L, Jiang S, Xu J, Lei X, Zhang J Matern Child Nutr. 2021; 18(1):e13235.

PMID: 34291873 PMC: 8710114. DOI: 10.1111/mcn.13235.


References
1.
Tung I, Li J, Meza J, Jezior K, Kianmahd J, Hentschel P . Patterns of Comorbidity Among Girls With ADHD: A Meta-analysis. Pediatrics. 2016; 138(4). PMC: 9923580. DOI: 10.1542/peds.2016-0430. View

2.
Sprich S, Safren S, Finkelstein D, Remmert J, Hammerness P . A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents. J Child Psychol Psychiatry. 2016; 57(11):1218-1226. PMC: 5026858. DOI: 10.1111/jcpp.12549. View

3.
Wolraich M, Brown L, Brown R, DuPaul G, Earls M, Feldman H . ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011; 128(5):1007-22. PMC: 4500647. DOI: 10.1542/peds.2011-2654. View

4.
Wilens T, Biederman J, Brown S, Tanguay S, Monuteaux M, Blake C . Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD. J Am Acad Child Adolesc Psychiatry. 2002; 41(3):262-8. DOI: 10.1097/00004583-200203000-00005. View

5.
Cuffe S, Visser S, Holbrook J, Danielson M, Geryk L, Wolraich M . ADHD and Psychiatric Comorbidity: Functional Outcomes in a School-Based Sample of Children. J Atten Disord. 2015; 24(9):1345-1354. PMC: 4879105. DOI: 10.1177/1087054715613437. View